E6 proteins from multiple human betapapillomavirus types degrade bak and protect keratinocytes from apoptosis after UVB irradiation

Journal of Virology

Volumn 82, Issue 21, 2008, Pages 10408-10417

  Underbrink, Michael P ^a,b,c   Howie, Heather L ^a   Bedard, Kristin M ^a   Koop, Jennifer I ^a   Galloway, Denise A ^a  

^a Fred Hutchinson Cancer Research Center   (United States)

^b UNIVERSITY OF WASHINGTON MEDICAL CENTER   (United States)

^c UNIVERSITY OF TEXAS MEDICAL BRANCH   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

PROTEIN BAK; PROTEIN BCL 2; PROTEIN E6; UBIQUITIN PROTEIN LIGASE E3; BAK1 PROTEIN, HUMAN; CASPASE 3; CYTOCHROME C; ONCOPROTEIN; UBE3A PROTEIN, HUMAN; UBIQUITIN PROTEIN LIGASE;

APOPTOSIS; ARTICLE; BETAPAPILLOMAVIRUS; CELL PROTECTION; CONTROLLED STUDY; HUMAN; HUMAN CELL; HUMAN PAPILLOMAVIRUS TYPE 16; KERATINOCYTE; PRIORITY JOURNAL; PROTEIN DEGRADATION; PROTEIN EXPRESSION; ULTRAVIOLET B RADIATION; ALPHAPAPILLOMAVIRUS; CELL CULTURE; CELL LINE; DRUG ANTAGONISM; METABOLISM; PHYSIOLOGY; RADIATION EXPOSURE; ULTRAVIOLET RADIATION; VIROLOGY;

BETAPAPILLOMAVIRUS; HUMAN PAPILLOMAVIRUS; HUMAN PAPILLOMAVIRUS TYPES;

ALPHAPAPILLOMAVIRUS; APOPTOSIS; BCL-2 HOMOLOGOUS ANTAGONIST-KILLER PROTEIN; BETAPAPILLOMAVIRUS; CASPASE 3; CELL LINE; CELLS, CULTURED; CYTOCHROMES C; HUMANS; KERATINOCYTES; ONCOGENE PROTEINS, VIRAL; UBIQUITIN-PROTEIN LIGASES; ULTRAVIOLET RAYS;

EID: 55249122277     PISSN: 0022538X     EISSN: None     Source Type: Journal    
DOI: 10.1128/JVI.00902-08     Document Type: Article

References (43)

1. Accardi, R., W. Dong, A. Smet, R. Cui, A. Hautefeuille, A. S. Gabet, B. S. Sylla, L. Gissmann, P. Hainaut, and M. Tommasino. 2006. Skin human papillomavirus type 38 alters p53 functions by accumulation of deltaNp73. EMBO Rep. 7:334-340.
2. Akgul, B., W. Lemme, R. Garcia-Escudero, A. Storey, and H. J. Pfister. 2005. UV-B irradiation stimulates the promoter activity of the high-risk, cutaneous human papillomavirus 5 and 8 in primary keratinocytes. Arch. Virol. 150:145-151.
3. Antignani, A., and R. J. Youle. 2006. How do Bax and Bak lead to permeabilization of the outer mitochondrial membrane? Curr. Opin. Cell Biol. 18:685-689.
4. Assefa, Z., A. Van Laethem, M. Garmyn, and P. Agostinis. 2005. Ultraviolet radiation-induced apoptosis in keratinocytes: on the role of cytosolic factors. Biochim. Biophys. Acta 1755:90-106.
5. Barbosa, M. S., W. C. Vass, D. R. Lowy, and J. T. Schiller. 1991. In vitro biological activities of the E6 and E7 genes vary among human papillomaviruses of different oncogenic potential. J. Virol. 65:292-298.
6. Bartz, S. R., and M. A. Vodicka. 1997. Production of high-titer human immunodeficiency virus type 1 pseudotyped with vesicular stomatitis virus glycoprotein. Methods 12:337-342.
7. Bedard, K. M., M. P. Underbrink, H. L. Howie, and D. A. Galloway. 2008. The E6 oncoproteins from human betapapillomaviruses differentially activate telomerase through an E6AP-dependent mechanism and prolong the lifespan of primary keratinocytes. J. Virol. 82:3894-3902.
8. Bouwes Bavinck, J. N., M. Feltkamp, L. Struijk, and J. ter Schegget. 2001. Human papillomavirus infection and skin cancer risk in organ transplant recipients. J. Investig. Dermatol. Symp. Proc. 6:207-211.
9. Caldeira, S., I. Zehbe, R. Accardi, I. Malanchi, W. Dong, M. Giarre, E. M. de Villiers, R. Filotico, P. Boukamp, and M. Tommasino. 2003. The E6 and E7 proteins of the cutaneous human papillomavirus type 38 display transforming properties. J. Virol. 77:2195-2206.
10. Chow, J., and V. A. Tron. 2005. Molecular aspects of ultraviolet radiation-induced apoptosis in the skin. J. Cutan. Med. Surg. 9:289-295.
11. Cogliano, V., R. Baan, K. Straif, Y. Grosse, B. Secretan, and F. El Ghissassi. 2005. Carcinogenicity of human papillomaviruses. Lancet Oncol. 6:204.
12. de Villiers, E. M., C. Fauquet, T. R. Broker, H. U. Bernard, and H. zur Hausen. 2004. Classification of papillomaviruses. Virology 324:17-27.
13. Finzer, P., A. Aguilar-Lemarroy, and F. Rosl. 2002. The role of human papillomavirus oncoproteins E6 and E7 in apoptosis. Cancer Lett. 188:15-24.
14. Foster, S. A., G. W. Demers, B. G. Etscheid, and D. A. Galloway. 1994. The ability of human papillomavirus E6 proteins to target p53 for degradation in vivo correlates with their ability to abrogate actinomycin D-induced growth arrest. J. Virol. 68:5698-5705.
15. Furumoto, H., and M. Irahara. 2002. Human papilloma virus (HPV) and cervical cancer. J. Med. Investig. 49:124-133.
16. Gewin, L., and D. A. Galloway. 2001. E box-dependent activation of telomerase by human papillomavirus type 16 E6 does not require induction of c-myc. J. Virol. 75:7198-7201.
17. Gewin, L., H. Myers, T. Kiyono, and D. A. Galloway. 2004. Identification of a novel telomerase repressor that interacts with the human papillomavirus type-16 E6/E6-AP complex. Genes Dev. 18:2269-2282.
18. Giampieri, S., and A. Storey. 2004. Repair of UV-induced thymine dimers is compromised in cells expressing the E6 protein from human papillomaviruses types 5 and 18. Br. J. Cancer 90:2203-2209.
19. Huibregtse, J. M., M. Scheffner, S. Beaudenon, and P. M. Howley. 1995. A family of proteins structurally and functionally related to the E6-AP ubiquitin-protein ligase. Proc. Natl. Acad. Sci. USA 92:5249.
20. Huibregtse, J. M., M. Scheffner, and P. M. Howley. 1993. Localization of the E6-AP regions that direct human papillomavirus E6 binding, association with p53, and ubiquitination of associated proteins. Mol. Cell. Biol. 13:4918-4927.
21. Jackson, S., C. Harwood, M. Thomas, L. Banks, and A. Storey. 2000. Role of Bak in UV-induced apoptosis in skin cancer and abrogation by HPV E6 proteins. Genes Dev. 14:3065-3073.
22. Jackson, S., and A. Storey. 2000. E6 proteins from diverse cutaneous HPV types inhibit apoptosis in response to UV damage. Oncogene 19:592-598.
23. Karagas, M. R., H. H. Nelson, P. Sehr, T. Waterboer, T. A. Stukel, A. Andrew, A. C. Green, J. N. Bavinck, A. Perry, S. Spencer, J. R. Rees, L. A. Mott, and M. Pawlita. 2006. Human papillomavirus infection and incidence of squamous cell and basal cell carcinomas of the skin. J. Natl. Cancer Inst. 98:389-395.
24. Latonen, L., and M. Laiho. 2005. Cellular UV damage responses - functions of tumor suppressor p53. Biochim. Biophys. Acta 1755:71-89.
25. Leffell, D. J. 2000. The scientific basis of skin cancer. J. Am. Acad. Dermatol. 42:18-22.
26. Li, X., and P. Coffino. 1996. High-risk human papillomavirus E6 protein has two distinct binding sites within p53, of which only one determines degradation. J. Virol. 70:4509-4516.
27. Lutzner, M. A., C. Blanchet-Bardon, and G. Orth. 1984. Clinical observations, virologic studies, and treatment trials in patients with epidermodysplasia verruciformis, a disease induced by specific human papillomaviruses. J. Investig. Dermatol. 83:18s-25s.
28. Munger, K., W. C. Phelps, V. Bubb, P. M. Howley, and R. Schlegel. 1989. The E6 and E7 genes of the human papillomavirus type 16 together are necessary and sufficient for transformation of primary human keratinocytes. J. Virol. 63:4417-4421.
29. Nijhawan, D., M. Fang, E. Traer, Q. Zhong, W. Gao, F. Du, and X. Wang. 2003. Elimination of Mcl-1 is required for the initiation of apoptosis following ultraviolet irradiation. Genes Dev. 17:1475-1486.
30. Orth, G., S. Jablonska, M. Jarzabek-Chorzelska, S. Obalek, G. Rzesa, M. Favre, and O. Croissant. 1979. Characteristics of the lesions and risk of malignant conversion associated with the type of human papillomavirus involved in epidermodysplasia verruciformis. Cancer Res. 39:1074-1082.
31. Patel, D., S. M. Huang, L. A. Baglia, and D. J. McCance. 1999. The E6 protein of human papillomavirus type 16 binds to and inhibits co-activation by CBP and p300. EMBO J. 18:5061-5072.
32. Pfister, H. 1992. Human papillomaviruses and skin cancer. Semin. Cancer Biol. 3:263-271.
33. Pfister, H., P. G. Fuchs, S. Majewski, S. Jablonska, I. Pniewska, and M. Malejczyk. 2003. High prevalence of epidermodysplasia verruciformis-associated human papillomavirus DNA in actinic keratoses of the immunocompetent population. Arch. Dermatol. Res. 295:273-279.
34. Storey, A., K. Osborn, and L. Crawford. 1990. Co-transformation by human papillomavirus types 6 and 11. J. Gen. Virol. 71:165-171.
35. Struijk, L., L. Hall, E. van der Meijden, P. Wanningen, J. N. Bavinck, R. Neale, A. C. Green, J. Ter Schegget, and M. C. Feltkamp. 2006. Markers of cutaneous human papillomavirus infection in individuals with tumor-free skin, actinic keratoses, and squamous cell carcinoma. Cancer Epidemiol. Biomarkers Prev. 15:529-535.
36. Thomas, M., and L. Banks. 1999. Human papillomavirus (HPV) E6 interactions with Bak are conserved amongst E6 proteins from high and low risk HPV types. J. Gen. Virol. 80:1513-1517.
37. Thomas, M., and L. Banks. 1998. Inhibition of Bak-induced apoptosis by HPV-18 E6. Oncogene 17:2943-2954.
38. Thomas, M., D. Pim, and L. Banks. 1999. The role of the E6-p53 interaction in the molecular pathogenesis of HPV. Oncogene 18:7690-7700.
39. Weissenborn, S. J., I. Nindl, K. Purdie, C. Harwood, C. Proby, J. Breuer, S. Majewski, H. Pfister, and U. Wieland. 2005. Human papillomavirus-DNA loads in actinic keratoses exceed those in non-melanoma skin cancers. J. Investig. Dermatol. 125:93-97.
40. Willis, S. N., and J. M. Adams. 2005. Life in the balance: how BH3-only proteins induce apoptosis. Curr. Opin. Cell Biol. 17:617-625.
41. Willis, S. N., L. Chen, G. Dewson, A. Wei, E. Naik, J. I. Fletcher, J. M. Adams, and D. C. Huang. 2005. Proapoptotic Bak is sequestered by Mcl-1 and Bcl-xL, but not Bcl-2, until displaced by BH3-only proteins. Genes Dev. 19:1294-1305.
42. zur Hausen, H. 2002. Papillomaviruses and cancer: from basic studies to clinical application. Nat. Rev. Cancer 2:342-350.
43. zur Hausen, H. 1999. Papillomaviruses in human cancers. Proc. Assoc. Am. Physicians 111:581-587.